Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pallavi Kulkarni

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Molecular Cancer|March 9, 2024
Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicineAnmi Jose, Pallavi Kulkarni, Jaya Thilakan, et al.
Psycho-Oncology|May 25, 2023
Effectiveness of smoking cessation interventions among persons with cancer: A systematic reviewJessica M Yingst, Matthew Carrillo, Kimberly H Chan, et al.
Frontiers in Cell and Developmental Biology|November 21, 2025
Bioinformatics insights into <i>TMPO-AS1-let-7b-5p-ESPL1/E2F8</i> regulatory axis in breast cancerRajeev Nema, Prerna Vats, Aditi Singh, et al.
The Journal of the Association of Physicians of India|July 14, 2022
Study of the Efficacy of Uptitrating Teneligliptin Dose from Standard Dose (20 mg) to High Dose (40 mg) in Patients with Type II Diabetes MellitusVijay Panikar, Shashank Joshi, Mangesh Tiwaskar, et al.
Oral Oncology|March 25, 2026
PTPR family deletions are associated with greater genomic structural instability in young adult tongue cancerPallavi Kulkarni, Kimberly Chan, Christopher Tseng, et al.
The Journal of the Association of Physicians of India|September 29, 2019
Efficacy of DPP4i as the Fourth Drug in the Management of Type2 Diabetes Mellitus in Asian Indians Poorly Controlled by Use of at least 3 Oral Antidiabetic DrugsVijay Panikar, Shashank Joshi, Mangesh Tiwaskar, et al.
The Journal of Biological Chemistry|July 5, 2022
Metalloprotease ADAM9 cleaves ephrin-B ligands and differentially regulates Wnt and mTOR signaling downstream of Akt kinase in colorectal cancer cellsPathirennehelage Chandrasekera, Mark Perfetto, Congyu Lu, et al.
Scientific Reports|August 5, 2025
Abacavir enhances the efficacy of doxorubicin via inhibition of histone demethylase KDM5B in breast cancerAnmi Jose, Pallavi Kulkarni, Naveena An Kumar, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Molecular Cancer|March 9, 2024
Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicineAnmi Jose, Pallavi Kulkarni, Jaya Thilakan, et al.
Psycho-Oncology|May 25, 2023
Effectiveness of smoking cessation interventions among persons with cancer: A systematic reviewJessica M Yingst, Matthew Carrillo, Kimberly H Chan, et al.
Frontiers in Cell and Developmental Biology|November 21, 2025
Bioinformatics insights into <i>TMPO-AS1-let-7b-5p-ESPL1/E2F8</i> regulatory axis in breast cancerRajeev Nema, Prerna Vats, Aditi Singh, et al.
The Journal of the Association of Physicians of India|July 14, 2022
Study of the Efficacy of Uptitrating Teneligliptin Dose from Standard Dose (20 mg) to High Dose (40 mg) in Patients with Type II Diabetes MellitusVijay Panikar, Shashank Joshi, Mangesh Tiwaskar, et al.
Oral Oncology|March 25, 2026
PTPR family deletions are associated with greater genomic structural instability in young adult tongue cancerPallavi Kulkarni, Kimberly Chan, Christopher Tseng, et al.
The Journal of the Association of Physicians of India|September 29, 2019
Efficacy of DPP4i as the Fourth Drug in the Management of Type2 Diabetes Mellitus in Asian Indians Poorly Controlled by Use of at least 3 Oral Antidiabetic DrugsVijay Panikar, Shashank Joshi, Mangesh Tiwaskar, et al.
The Journal of Biological Chemistry|July 5, 2022
Metalloprotease ADAM9 cleaves ephrin-B ligands and differentially regulates Wnt and mTOR signaling downstream of Akt kinase in colorectal cancer cellsPathirennehelage Chandrasekera, Mark Perfetto, Congyu Lu, et al.
Scientific Reports|August 5, 2025
Abacavir enhances the efficacy of doxorubicin via inhibition of histone demethylase KDM5B in breast cancerAnmi Jose, Pallavi Kulkarni, Naveena An Kumar, et al.
Pageof 2